Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00690118
Recruitment Status : Terminated (The interim analysis showed no tendency in favour of the verum group. Therefore it was decided to stop the study prematurely.)
First Posted : June 4, 2008
Last Update Posted : May 29, 2015
Information provided by (Responsible Party):
Albert Christian Ludolph, Prof., University of Ulm